Diamines & Chemicals' audit record was clean for seven straight years, but the FY2025-26 report breaks that streak with a going-concern paragraph after cash reserves fell from ₹21.88 crore to ₹15.73 lakh in a single year. The company lost ₹12.55 crore after tax, cash losses resumed with negative CFO of ₹10.85 crore, and borrowings jumped from ₹2.51 lakh to ₹8.19 crore. Behind that sits a related-party loan book of ₹9.58 crore with no repayment terms, a revenue base that has shrunk from ₹111 crore to ₹38 crore in three years, and a subsidiary and associate that have absorbed over ₹20 crore while generating negligible revenue.
Key findings
- The auditor now doubts the company can continue as a going concern
Critical- The FY2025-26 audit report includes a going-concern paragraph stating that events or conditions may cause the company to cease as a going concern. The statutory auditor issued unqualified opinions for every year from FY2019-20 through FY2025-26, with no Emphasis of Matter or material-uncertainty paragraphs in any prior year. Cash and cash equivalents fell to ₹15.73 lakh as of March 31, 2026, from 21.88 crore a year earlier, while current borrowings rose by 8.16 crore to 8.19 crore. - Related-party loans of ₹9.58 crore carry no repayment terms, and the auditor cannot assess repayment regularity
Major- Loans to wholly owned subsidiary DACL Fine Chem Limited rose from ₹21.06 lakhs in FY2022-23 to ₹6.74 crore in FY2025-26 at 11.65% p.a., while loans to associate KLJ Organic Diamines Limited stood at ₹2.84 crore at 8% p.a.. The auditor's CARO report, a regulatory annexure on company law compliance, has stated for four straight years that repayment terms have not been stipulated and the company has not demanded repayment, so the auditor is unable to comment on regularity of repayment. These loans represent 100% of total loans in each year, aggregating ₹9.58 crore in FY2025-26. - Revenue collapsed from ₹111 crore to ₹38 crore in three years, and doubtful-receivable provisions nearly tripled
Major- Speciality Chemicals segment revenue fell from ₹111 crore in FY23 to ₹89.27 crore in FY24 to ₹67.64 crore in FY25 to ₹38.48 crore in FY26. A customer that once contributed 29% or more of revenue in FY2019-20, amounting to ₹19.9 crore, shrank to ₹7.26 crore in FY2024-25, and no customer contributed 10% or more in FY2025-26. The provision for doubtful receivables rose to 5.69 crore for the year ended March 31, 2026, from 2.08 crore a year earlier. - A wholly owned subsidiary and a 35% associate have absorbed ₹20+ crore while generating negligible revenue and recurring losses
Major- DACL Fine Chem Limited, incorporated July 30, 2020, reported total revenues of ₹4.95 lakhs and a net loss of 1.52 crore for FY2025-26, with cumulative losses across five years. The company's investment in the subsidiary stood at ₹13.45 crore with unsecured loans of ₹6.74 crore, while the associate KLJ Organic Diamines Limited, which had not commenced commercial activity as of March 31, 2026, held an investment of ₹1.75 crore and loans of ₹2.84 crore. The Board approved investment of up to ₹20 crore in the subsidiary on October 24, 2024, for land procurement, professional fees, and deleveraging. - Operating cash flow covers only 0.58x of EBITDA across the cycle, and FY2025-26 began with cash nearly wiped out
Major- Cumulative CFO of ₹77 crore covered only 0.58x of cumulative EBITDA of ₹132 crore over the ten-year history. FY2025-26 CFO was negative ₹10.85 crore against a PAT of negative ₹12.55 crore, following FY2024-25 CFO of negative ₹5.02 crore against PAT of ₹2.95 crore. FY2024-25 free cash flow was negative ₹8.97 crore, after positive FCF of ₹13.40 crore in FY2023-24. - A preferential warrant issue transferred ₹8.79 crore of unexercised warrant money to capital reserve, bypassing the profit and loss statement
Major- The company allotted 9,06,390 warrants on October 1, 2024 at ₹552 each; only 2,69,402 were converted into equity shares on March 24, 2026, and 6,36,988 warrants lapsed as at March 31, 2026. On conversion, ₹26.94 lakh went to equity share capital and ₹14.6 crore to securities premium, while ₹8.79 crore pertaining to unexercised warrants was transferred to capital reserve as forfeited amount. The exercise money of ₹11,15,32,428 from 8 allottees was yet to be utilized as on March 31, 2026. - FY2026's loss is softened by a deferred-tax credit, an inventory write-back, and an impairment reversal
Major- The company recognised a deferred tax credit of 1.15 crore and an earlier-year tax credit of ₹26.28 lakhs, producing a total income tax credit of 1.41 crore for the year ended March 31, 2026, against a prior-year tax expense of 1.83 crore. It wrote back inventories of ₹1.4 crore previously written down to net realisable value, and recognised an impairment reversal of Property, Plant & Equipment of ₹84.43 lakhs. Separately, it recorded a capital reserve of 8.79 crore from forfeited application money on unexercised share warrants. - Only minor penalties for delayed director-change filings, with no major regulatory actions across FY2020-FY2026
Clean- In FY2025-26, the company received a penalty of ₹10,000 under the Gujarat Prohibition Act, 1949 for delay in providing information of change in Directors, and in FY2024-25 a penalty of ₹15,000 for the same reason. No penalties or strictures were imposed by Stock Exchange, SEBI, or any other regulatory authority in FY2023-24 or FY2021-22.
What to watch
- 49th AGM loan disclosures. Section 186 particulars of the outstanding loans to DACL Fine Chem Limited (₹6,73,94,227 at 11.65% p.a.) and KLJ Organic Diamines Limited (₹2,84,40,958 at 8% p.a.) will be placed before shareholders at the 49th Annual General Meeting scheduled for September 16, 2026.
- Going-concern resolution. The FY2025-26 going-concern paragraph in the audit report dated 18 May 2026 signals potential material uncertainty that may be addressed in the FY2026-27 audit report.
- Borrowings and cash rebuild. As of the FY2025-26 Annual Report period ended March 31, 2026, monitor whether the 8.19 crore in current borrowings is repaid or refinanced and whether cash reserves rebuild from the ₹15.73 lakh low.
- Warrant proceeds deployment. As of the FY2025-26 Annual Report period ended March 31, 2026, monitor deployment of the 11.15 crore equity/warrant proceeds and whether any portion funds operating losses rather than stated capex.
- Income tax resolution. Resolution of the ₹10.03 crore income tax contingent liability and recovery of the ₹1.19 crore paid but not expensed, as disclosed in the FY2025-26 Annual Report.
Bottom line: This is a company whose audit record was clean until the FY2025-26 report introduced a going-concern paragraph, and whose cash position has deteriorated to the point where survival depends on the success of recent capital raises and the resolution of related-party exposures. The risk is concentrated in the ₹9.58 crore of related-party loans with no repayment terms, the ₹20+ crore absorbed by a loss-making subsidiary and a non-operational associate, and the collapse of the core revenue base. Watch the September 16, 2026 AGM disclosures, the FY2026-27 audit report, and whether the warrant proceeds rebuild cash or fund operating losses.